International Proteolysis Society (IPS) Symposium: Proteases in SARS-CoV2 Infections

Joint ProtPath and IPS Symposium: logo

January 20^th, 2022

17:00 (CET), 8:00 am (PDT), 9:00 am (MST), 11:00 am (EST)

online via Zoom

The Symposium is free of charge. Register here by January 12^th, 2022. Fully booked! Sorry, registration is closed!

Registrations before January 10^th are accepted. January 11^th: meeting is almost full, places will be given according to time of registration.

confirmed speakers:

	Rolf Hilgenfeld, University of Lübeck, Germany The SARS COV-2 main protease - inhibitors, structures and mutations 17:00-17:45 CET, 8:00-8:45 PDT
	Wioletta Rut, the Wrocław University of Technology, Poland (Assistant Professor) SARS-CoV-2 Mpro and PLpro as attractive targets in COVID-19 therapy 18:00-18:20 CET, 9:00-9:20 PDT
	Joanne Lemieux, University of Alberta, Canada Antiviral drug development targeting the SARS-CoV-2 main protease 18:30-18:50 CET, 9:30-9:50 PDT
	Isabel Pablos, University of British Columbia, Canada (Post-doctoral fellow in the lab of Chris Overall) SARS-CoV-2 main protease 3CLpro cleaves key cellular substrates involved in translation, proliferation and antiviral autophagy 19:00 - 19:20 CET, 10:00-10:20 PDT
	James W. Janetka, Washington University, Medical Campus, USA Multi-effect protease inhibitors block SARS-CoV-2 viral entry and COVID-19 pathogenesis 19:30-19:50 CET, 10:30-10:50 PDT
	Georg Jocher, German Center for Neurodegenerative Diseases (DZNE), München, Germany (PhD student in the lab of Stefan F. Lichtenthaler) ADAM proteases are host factors of SARS-CoV-2 cell entry and pathogenesis 19:50-20:10 CET, 10:50-11:10 PDT
	Chair: Ruth Geiss-Friedlander, Albert-Ludwigs-University Freiburg, Freiburg, Germany IPS Vice President
	Chair: Anthony O’Donoghue, University of California, San Diego, USA IPS President